Merrimack Pharmaceuticals, Inc. | ||||
NGM : MACK || Location: United States | ||||
$14.77+0.02 (+0.14%) |
0.4 M | 14.75 - 14.85 | ||
Last Updated:America/New_York | Volume | Day range |
Short Interest
Short Date | Short Interest |
---|---|
March 15, 2024 | 0.730 M |
Feb. 29, 2024 | 0.774 M |
Feb. 15, 2024 | 0.823 M |
Jan. 31, 2024 | 0.763 M |
Jan. 12, 2024 | 0.752 M |
EPS Surprise
Period | Estimate | Actual | Surprise |
---|---|---|---|
09/30/2018 | -0.28 | -0.92 | -234.06% |
06/30/2018 | -1.31 | -1.33 | -1.60% |
03/31/2018 | -1.18 | -1.33 | -12.89% |
12/31/2017 | -0.29 | -1.08 | -273.70% |
Recent Dividends
Div Date | Div Amount |
---|---|
12/13/2019 | 0.50 |
09/06/2019 | 1.50 |
05/30/2017 | 1.06 |
Sector | Healthcare | Industry | Biotechnology |
Shares Outstanding | 14.532M | Shares Float | 9.396M |
Short Float | 0.730M | Market Cap | 214.35M |
Institution ownership | 66.68% | Insider ownership | 1.212% |
Earnings Date | 05/02/2024 AMC | Cash Per Share | ? |
Trailing EPS | -0.08 | Forward EPS | -1.78 |